130
Participants
Start Date
August 20, 2020
Primary Completion Date
December 4, 2020
Study Completion Date
December 10, 2021
HA+Lidocaine
20 mg
HA
Beijing, Beijing
Shanghai, Shanghai
SciVision Biotech Inc.
INDUSTRY